Publicacións en colaboración con investigadores/as de University of Manitoba (8)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2020

  1. Cervico-Vaginal Inflammatory Cytokine and Chemokine Responses to Two Different SIV Immunogens

    Frontiers in Immunology, Vol. 11

  2. Technological challenges in the preclinical development of an HIV nanovaccine candidate

    Drug Delivery and Translational Research, Vol. 10, Núm. 3, pp. 621-634

  3. Vaccine targeting SIVmac251 protease cleavage sites protects macaques against vaginal infection

    Journal of Clinical Investigation, Vol. 130, Núm. 12, pp. 6429-6442

2019

  1. Polysaccharide Nanoparticles Can Efficiently Modulate the Immune Response against an HIV Peptide Antigen

    ACS Nano, Vol. 13, Núm. 5, pp. 4947-4959

2016

  1. Erratum: Genome of Rhodnius prolixus, an insect vector of Chagas disease, reveals unique adaptations to hematophagy and parasite infection (Proceedings of the National Academy of Sciences of the United States of America (2015) 112 (14936-14941) DOI 10.1073/pnas.1506226112)

    Proceedings of the National Academy of Sciences of the United States of America

2015

  1. Genome of Rhodnius prolixus, an insect vector of Chagas disease, reveals unique adaptations to hematophagy and parasite infection

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 112, Núm. 48, pp. 14936-14941